{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:16:31Z","timestamp":1781158591009,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-025-07874-2","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:39:42Z","timestamp":1768041582000},"page":"1257-1265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency"],"prefix":"10.1007","volume":"45","author":[{"given":"Berkay","family":"Aktas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerem","family":"Parlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alperen","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Uc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beste","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-2282","authenticated-orcid":false,"given":"Serdal","family":"Ugurlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"9103","key":"7874_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","volume":"351","author":"E Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351(9103):659\u2013664. https:\/\/doi.org\/10.1016\/S0140-6736(97)09408-7","journal-title":"Lancet"},{"issue":"11","key":"7874_CR2","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.3390\/ijms24119584","volume":"24","author":"M Lancieri","year":"2023","unstructured":"Lancieri M, Bustaffa M, Palmeri S et al (2023) An update on familial Mediterranean fever. Int J Mol Sci 24(11):9584. https:\/\/doi.org\/10.3390\/ijms24119584","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7874_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/rheumatology\/kead439","volume":"63","author":"E Ben-Chetrit","year":"2024","unstructured":"Ben-Chetrit E (2024) Old paradigms and new concepts in familial Mediterranean fever (FMF): an update 2023. Rheumatology (Oxford) 63(2):309\u2013318. https:\/\/doi.org\/10.1093\/rheumatology\/kead439","journal-title":"Rheumatology (Oxford)"},{"issue":"1 Pt 2","key":"7874_CR4","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.lpm.2018.08.014","volume":"48","author":"H Ozdogan","year":"2019","unstructured":"Ozdogan H, Ugurlu S (2019) Familial Mediterranean fever. Presse Med 48(1 Pt 2):e61\u2013e76. https:\/\/doi.org\/10.1016\/j.lpm.2018.08.014","journal-title":"Presse Med"},{"issue":"8","key":"7874_CR5","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10067-017-3715-5","volume":"36","author":"M Alghamdi","year":"2017","unstructured":"Alghamdi M (2017) Familial Mediterranean fever, review of the literature. Clin Rheumatol 36(8):1707\u20131713. https:\/\/doi.org\/10.1007\/s10067-017-3715-5","journal-title":"Clin Rheumatol"},{"issue":"10","key":"7874_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/medicina57101049","volume":"57","author":"R Siligato","year":"2021","unstructured":"Siligato R, Gembillo G, Calabrese V, Conti G, Santoro D (2021) Amyloidosis and glomerular diseases in familial Mediterranean fever. Medicina (Kaunas) 57(10):1049. https:\/\/doi.org\/10.3390\/medicina57101049","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"7874_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ard.2025.01.028","volume":"84","author":"S Ozen","year":"2025","unstructured":"Ozen S, Sa\u011f E, Oton T et al (2025) EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Ann Rheum Dis 84(6):899\u2013909. https:\/\/doi.org\/10.1016\/j.ard.2025.01.028","journal-title":"Ann Rheum Dis"},{"key":"7874_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fimmu.2017.00253","volume":"8","author":"S \u00d6zen","year":"2017","unstructured":"\u00d6zen S, Batu ED, Demir S (2017) Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management. Front Immunol 8:253. https:\/\/doi.org\/10.3389\/fimmu.2017.00253","journal-title":"Front Immunol"},{"issue":"1","key":"7874_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00780-w","volume":"21","author":"K Cohen","year":"2023","unstructured":"Cohen K, Spielman S, Semo-Oz R et al (2023) Colchicine treatment can be discontinued in a selected group of pediatric FMF patients. Pediatr Rheumatol Online J 21(1):2. https:\/\/doi.org\/10.1186\/s12969-022-00780-w","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"7874_CR10","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/rheumatology\/kez156","volume":"58","author":"A Tanatar","year":"2019","unstructured":"Tanatar A, Karada\u011f \u015eG, S\u00f6nmez HE, \u00c7akan M, Aktay Ayaz N (2019) Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit? Rheumatology (Oxford) 58(10):1818\u20131821. https:\/\/doi.org\/10.1093\/rheumatology\/kez156","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"7874_CR11","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3899\/jrheum.201158","volume":"48","author":"YB Aviel","year":"2021","unstructured":"Aviel YB, Rawan S, Fahoum S, Wexler I, Berkun Y (2021) Discontinuation of colchicine therapy in children with familial Mediterranean fever. J Rheumatol 48(11):1732\u20131735. https:\/\/doi.org\/10.3899\/jrheum.201158","journal-title":"J Rheumatol"},{"issue":"2","key":"7874_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10067-016-3421-8","volume":"36","author":"HE S\u00f6nmez","year":"2017","unstructured":"S\u00f6nmez HE, Batu ED, Bilginer Y, \u00d6zen S (2017) Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean Fever) variants. Clin Rheumatol 36(2):421\u2013425. https:\/\/doi.org\/10.1007\/s10067-016-3421-8","journal-title":"Clin Rheumatol"},{"key":"7874_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf340","author":"V Cam","year":"2025","unstructured":"Cam V, Unal D, Sag E et al (2025) Re-evaluation of MEFV carriers previously diagnosed with familial Mediterranean fever: a colchicine discontinuation study. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keaf340","journal-title":"Rheumatology (Oxford)"},{"key":"7874_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1172-9-3","volume":"9","author":"I Ben-Zvi","year":"2014","unstructured":"Ben-Zvi I, Krichely-Vachdi T, Feld O, Lidar M, Kivity S, Livneh A (2014) Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study. Orphanet J Rare Dis 9:3. https:\/\/doi.org\/10.1186\/1750-1172-9-3","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"7874_CR15","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879\u20131885. https:\/\/doi.org\/10.1002\/art.1780401023","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7874_CR16","doi-asserted-by":"publisher","first-page":"103532","DOI":"10.1016\/j.ejmg.2018.08.013","volume":"62","author":"C Grossman","year":"2019","unstructured":"Grossman C, Kassel Y, Livneh A, Ben-Zvi I (2019) Familial Mediterranean fever (FMF) phenotype in patients homozygous to the MEFV M694V mutation. Eur J Med Genet 62(6):103532. https:\/\/doi.org\/10.1016\/j.ejmg.2018.08.013","journal-title":"Eur J Med Genet"},{"issue":"6","key":"7874_CR17","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kez410","volume":"59","author":"B Balc\u0131-Peynircio\u011flu","year":"2020","unstructured":"Balc\u0131-Peynircio\u011flu B, Kaya-Ak\u00e7a \u00dc, Ar\u0131c\u0131 ZS et al (2020) Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford) 59(6):1372\u20131380. https:\/\/doi.org\/10.1093\/rheumatology\/kez410","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7874_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/rheumatology\/kei279","volume":"45","author":"HJ Lachmann","year":"2006","unstructured":"Lachmann HJ, Seng\u00fcl B, Yavuz\u015fen TU et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746\u2013750. https:\/\/doi.org\/10.1093\/rheumatology\/kei279","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"7874_CR19","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3390\/cells11121979","volume":"11","author":"J Austermann","year":"2022","unstructured":"Austermann J, Roth J, Barczyk-Kahlert K (2022) The good and the bad: monocytes\u2019 and macrophages\u2019 diverse functions in inflammation. Cells 11(12):1979. https:\/\/doi.org\/10.3390\/cells11121979","journal-title":"Cells"},{"issue":"16","key":"7874_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D Zemer","year":"1986","unstructured":"Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314(16):1001\u20131005. https:\/\/doi.org\/10.1056\/NEJM198604173141601","journal-title":"N Engl J Med"},{"issue":"7","key":"7874_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/sj.ejhg.5200674","volume":"9","author":"E Yilmaz","year":"2001","unstructured":"Yilmaz E, Ozen S, Balci B et al (2001) Mutation frequency of Familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9(7):553\u2013555. https:\/\/doi.org\/10.1038\/sj.ejhg.5200674","journal-title":"Eur J Hum Genet"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07874-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07874-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07874-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:40Z","timestamp":1769763760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07874-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7874"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07874-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Istanbul University\u2013Cerrahpa\u015fa Faculty of Medicine ethics committee granted full ethical approval (approval no: RUQt267D) for this study and waived the requirement for informed consent due to the retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors approved the final version of the manuscript and consented to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}